Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Amicus Therapeutics (FOLD)

Amicus Therapeutics (FOLD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,495,801
  • Shares Outstanding, K 260,588
  • Annual Sales, $ 182,240 K
  • Annual Income, $ -356,390 K
  • 60-Month Beta 1.57
  • Price/Sales 22.10
  • Price/Cash Flow N/A
  • Price/Book 16.45
Trade FOLD with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.23
  • Number of Estimates 4
  • High Estimate -0.22
  • Low Estimate -0.25
  • Prior Year -0.35
  • Growth Rate Est. (year over year) +34.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.70 +3.76%
on 01/22/21
24.84 -17.71%
on 01/06/21
-3.79 (-15.64%)
since 12/24/20
3-Month
17.20 +18.84%
on 10/26/20
25.39 -19.50%
on 12/22/20
+1.96 (+10.61%)
since 10/23/20
52-Week
6.25 +227.04%
on 03/16/20
25.39 -19.50%
on 12/22/20
+11.50 (+128.64%)
since 01/24/20

Most Recent Stories

More News
Amicus Therapeutics Announces Presentations and Posters at the 17th Annual WORLDSymposium(TM) 2021

Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, today announced that three oral...

FOLD : 20.44 (-3.08%)
Amicus Therapeutics Reports Preliminary 2020 Revenue and Provides 2021 Outlook

Full-Year 2020 Galafold Revenue of ~$261M Exceeds Guidance

FOLD : 20.44 (-3.08%)
Amicus Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley, Chairman and Chief Executive Officer, will present at the 39 Annual J.P. Morgan Healthcare Conference, being held virtually on Tuesday,...

JPM : 132.12 (-1.25%)
FOLD : 20.44 (-3.08%)
44.6% Return Seen to Date on SmarTrend Amicus Therapeut Call (FOLD)

SmarTrend identified an Uptrend for Amicus Therapeut (NASDAQ:FOLD) on October 13th, 2020 at $15.95. In approximately 3 months, Amicus Therapeut has returned 44.62% as of today's recent price of $23.06....

FOLD : 20.44 (-3.08%)
Amicus Therapeut Has Returned 56.2% Since SmarTrend Recommendation (FOLD)

SmarTrend identified an Uptrend for Amicus Therapeut (NASDAQ:FOLD) on October 13th, 2020 at $15.95. In approximately 2 months, Amicus Therapeut has returned 56.22% as of today's recent price of $24.91....

FOLD : 20.44 (-3.08%)
5 Biotech Stocks That More Than Doubled This Year

The biotech sector has been in focus through 2020 as companies like Moderna (MRNA) strive hard to develop a vaccine for COVID-19.

ALXN : 161.32 (+1.00%)
MRNA : 147.00 (+12.20%)
FOLD : 20.44 (-3.08%)
FATE : 96.14 (-1.08%)
RARE : 146.76 (+4.48%)
XLRN : 125.88 (+1.02%)
EDIT : 65.47 (-0.44%)
Amicus Therapeutics (FOLD) Catches Eye: Stock Jumps 8.1%

Amicus Therapeutics (FOLD) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

FOLD : 20.44 (-3.08%)
PHMMF : 107.5000 (+1.18%)
Amicus Therapeut Shares Up 50.1% Since SmarTrend's Buy Recommendation (FOLD)

SmarTrend identified an Uptrend for Amicus Therapeut (NASDAQ:FOLD) on October 13th, 2020 at $15.95. In approximately 2 months, Amicus Therapeut has returned 50.08% as of today's recent price of $23.93....

FOLD : 20.44 (-3.08%)
Uptrend Call Working As Amicus Therapeut Stock Rises 48.9% (FOLD)

SmarTrend identified an Uptrend for Amicus Therapeut (NASDAQ:FOLD) on October 13th, 2020 at $15.95. In approximately 2 months, Amicus Therapeut has returned 48.95% as of today's recent price of $23.75....

FOLD : 20.44 (-3.08%)
Amicus Therapeutics Named a Great Place to Work-Certified(TM) Company in 2020

Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, today announced that it has been...

FOLD : 20.44 (-3.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilizeproteins in...

See More

Key Turning Points

3rd Resistance Point 22.69
2nd Resistance Point 22.01
1st Resistance Point 21.23
Last Price 20.44
1st Support Level 19.77
2nd Support Level 19.09
3rd Support Level 18.31

See More

52-Week High 25.39
Last Price 20.44
Fibonacci 61.8% 18.08
Fibonacci 50% 15.82
Fibonacci 38.2% 13.56
52-Week Low 6.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar